Soligenix Nabs Fast Track Status for RiVax By Sam | February 24, 2020 The company received funding for RiVax from the FDA and the National Institute of Allergy and Infectious Diseases (NIAID). Source: Devices & Diagnostics Letter Posted in Devices & Diagnostics Letter